Filing Details
- Accession Number:
- 0001203311-20-000138
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-08 19:33:14
- Reporting Period:
- 2020-12-04
- Accepted Time:
- 2020-12-08 19:33:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-04 | 6,824 | $15.46 | 722,033 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-04 | 6,824 | $180.00 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-04 | 14,908 | $15.46 | 730,117 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-04 | 14,908 | $179.17 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-07 | 1,080 | $15.46 | 716,289 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-07 | 1,080 | $178.36 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-07 | 1,741 | $15.46 | 716,950 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-07 | 1,741 | $179.40 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-07 | 3,590 | $15.46 | 718,799 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-07 | 3,590 | $180.25 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-07 | 3,352 | $15.46 | 718,561 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-07 | 3,352 | $181.38 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-07 | 5,056 | $15.46 | 720,265 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-07 | 5,056 | $182.49 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-07 | 904 | $15.46 | 716,113 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-07 | 904 | $182.97 | 715,209 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-12-04 | 6,824 | $0.00 | 6,824 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-12-04 | 14,908 | $0.00 | 14,908 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-12-07 | 1,080 | $0.00 | 1,080 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-12-07 | 1,741 | $0.00 | 1,741 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-12-07 | 3,590 | $0.00 | 3,590 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-12-07 | 3,352 | $0.00 | 3,352 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-12-07 | 5,056 | $0.00 | 5,056 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-12-07 | 904 | $0.00 | 904 | $15.46 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 265,455 | 2021-08-24 | No | 4 | M | Direct | |
| 250,547 | 2021-08-24 | No | 4 | M | Direct | |
| 249,467 | 2021-08-24 | No | 4 | M | Direct | |
| 247,726 | 2021-08-24 | No | 4 | M | Direct | |
| 244,136 | 2021-08-24 | No | 4 | M | Direct | |
| 240,784 | 2021-08-24 | No | 4 | M | Direct | |
| 235,728 | 2021-08-24 | No | 4 | M | Direct | |
| 234,824 | 2021-08-24 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $179.63 to $180.28. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $178.62 to $179.59 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $177.86 to $178.83 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $178.86 to $179.85. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $179.88 to $180.85. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $180.89 to $181.88. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $181.89 to $182.88. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $182.90 to $183.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options vested at a rate of 25% on 8/24/12 and monthly thereafter until all the shares were fully vested on 8/24/15.
Billionaire Hedge Funds
